Toggle Main Menu Toggle Search

Open Access padlockePrints

Clinical spectrum of paediatric and adult eosinophilic oesophagitis in the North East of England from 2016 to 2019

Lookup NU author(s): Dr Ben Shillitoe, Dr Louise MichaelisORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.Background and study aims: Eosinophilic oesophagitis (EoE) is a common disease with a significant impact on physical health and quality of life (QoL). Outcomes and management vary widely, with no agreed UK national guideline. This paper aims to describe an up-to-date description of demographics, clinical spectrum and outcomes for paediatric and adult patients with EoE from the North East of England between 2016 and 2019. Patients and methods: Patients from two large University Hospitals and the specialist paediatric hospital for the North East of England with histologically or clinically confirmed EoE were included in this analysis. Data were collected retrospectively via electronic patient records. Remission was defined as either the resolution of symptoms or improvement on histology. Results: Data were collected on 74 paediatric and 59 adult patients. Dysphagia was the most common presenting symptom in both groups, accounting for 51%-84% of all presentations. Proton pump inhibitors and dietary manipulation were the most common therapies associated with remission in children (95% of those achieving remission), whereas the use of swallowed topical steroids was more prevalent in the treatment of adults (55% achieving remission). Conclusions: EoE is a complex disease and poses significant challenges. Outcomes vary widely and need to be tailored to individual patient groups. Dietary manipulation plays a major role in treatment for EoE, but this is likely to be challenging for patients, especially children. Future work should continue to assess the outcomes in EoE, including on QoL and potential novel targeted therapies.

Publication metadata

Author(s): Shillitoe B, Lee JC, Hussien M, Beintaris I, Stothard M, Johnston M, Dallal HJ, Michaelis LJ, Attwood S, Dhar A

Publication type: Article

Publication status: Published

Journal: Frontline Gastroenterology

Year: 2021

Volume: 13

Issue: 3

Pages: 231-236

Online publication date: 08/06/2021

Acceptance date: 31/05/2021

ISSN (print): 2041-4137

ISSN (electronic): 2041-4145

Publisher: BMJ Publishing Group


DOI: 10.1136/flgastro-2021-101814


Altmetrics provided by Altmetric